Kadife, E.; Chan, E.; Luwor, R.; Kannourakis, G.; Findlay, J.; Ahmed, N.
Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer. Cancers 2019, 11, 243.
https://doi.org/10.3390/cancers11020243
AMA Style
Kadife E, Chan E, Luwor R, Kannourakis G, Findlay J, Ahmed N.
Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer. Cancers. 2019; 11(2):243.
https://doi.org/10.3390/cancers11020243
Chicago/Turabian Style
Kadife, Elif, Emily Chan, Rodney Luwor, George Kannourakis, Jock Findlay, and Nuzhat Ahmed.
2019. "Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer" Cancers 11, no. 2: 243.
https://doi.org/10.3390/cancers11020243
APA Style
Kadife, E., Chan, E., Luwor, R., Kannourakis, G., Findlay, J., & Ahmed, N.
(2019). Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer. Cancers, 11(2), 243.
https://doi.org/10.3390/cancers11020243